Cargando…
Prostate Cancer Progression: as a Matter of Fats
Advanced prostate cancer (PCa) represents the fifth cause of cancer death worldwide. Although survival has improved with second-generation androgen signaling and Parp inhibitors, the benefits are not long-lasting, and new therapeutic approaches are sorely needed. Lipids and their metabolism have rec...
Autores principales: | Scaglia, Natalia, Frontini-López, Yesica Romina, Zadra, Giorgia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353450/ https://www.ncbi.nlm.nih.gov/pubmed/34386430 http://dx.doi.org/10.3389/fonc.2021.719865 |
Ejemplares similares
-
When fat goes down, prostate cancer is on the ropes
por: Zadra, Giorgia, et al.
Publicado: (2019) -
Lactate as Key Metabolite in Prostate Cancer Progression: What Are the Clinical Implications?
por: Chetta, Paolo, et al.
Publicado: (2023) -
Perirenal fat metastasis of prostate cancer
por: Wakita, Teppei, et al.
Publicado: (2021) -
Metabolic reprogramming as an emerging mechanism of resistance to endocrine therapies in prostate cancer
por: Chetta, Paolo, et al.
Publicado: (2021) -
A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis
por: Zadra, Giorgia, et al.
Publicado: (2014)